Status:
COMPLETED
Music Therapy on Nausea and Pain for Autologous Stem Cell
Lead Sponsor:
Case Comprehensive Cancer Center
Conditions:
Multiple Myeloma
Non-Hodgkin Lymphoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Autologous stem cell transplant (ASCT) is an important therapy for patients with multiple myeloma, non-Hodgkin's lymphoma, and Hodgkin's lymphoma. It has been shown to improve progression free surviva...
Detailed Description
Patients randomized to receive music therapy will receive 2 sessions of live music therapy, at least 48 hours apart, from a Music Therapist-Board Certified (MT-BC, certified through the Certification ...
Eligibility Criteria
Inclusion
- Be older than 18 years of age
- Have a diagnosis of multiple myeloma, non-Hodgkin, or Hodgkin lymphoma
- Be undergoing ASCT (Autologous Stem Cell Transplantation)
Exclusion
- Have had previous ASCT
- Have a diagnosis of leukemia
- History of prior music therapy
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01487031
Start Date
November 1 2011
End Date
April 1 2013
Last Update
August 2 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44195